한글목차

바큐로바이러스 발현 시스템 시장은 2025년에 4억 3,600만 달러, 2032년까지 7억 8,180만 달러에 이르고, 2025-2032년 연평균 복합 성장률(CAGR)은 8.7%로 성장할 전망입니다.

바큐로바이러스 발현 시스템은 생명공학에서 재조합 단백질 생산에 매우 다재다능하고 널리 이용되고 있는 도구입니다. 박테리오바이러스는 곤충 세포에 감염되는 곤충 바이러스로, 원하는 외래 유전자를 발현하도록 조작되어 있습니다. 이 발현 시스템은 높은 단백질 수율, 번역 후 변형, 확장성 등 다른 발현 시스템에 비해 몇 가지 장점이 있습니다.

박테리오바이러스 발현 시스템은 바이오 의약품 생산, 단백질 연구, 백신 개발, 유전자 치료 등 다양한 분야에 적용되고 있습니다. 이 시스템은 수년 동안 광범위하게 연구되고 최적화되어 효율성과 범용성이 향상되었습니다.

시장 역학:

세계 박테리오바이러스 발현 시스템 시장은 향후 몇 년 동안 큰 성장이 예상됩니다. 이러한 성장의 원동력은 치료 및 연구 목적으로 재조합 단백질에 대한 수요 증가 등 몇 가지 요인에 기인합니다. 박테리오바이러스 발현 시스템은 복잡하고 기능적인 단백질을 대량으로 생산할 수 있기 때문에 바이오 제약 산업에서 선호되고 있습니다.

또 다른 시장 성장 촉진요인은 새로운 치료법과 백신 개발을 위한 연구개발 활동에 대한 투자가 증가하고 있다는 점입니다. 박테리오바이러스 발현 시스템은 이러한 생물학적 제제 생산에 신뢰할 수 있고 비용 효율적인 플랫폼을 제공합니다.

그러나 시장에는 일정한 억제요인도 있습니다. 주요 과제 중 하나는 박테리오바이러스 발현 시스템을 이용한 단백질 생산 공정이 복잡하고 시간이 많이 걸린다는 점입니다. 시스템의 최적화와 스케일업에는 기술적 전문 지식이 필요하며, 많은 노력이 필요합니다.

그러나 시장에는 수많은 성장 기회가 있습니다. 맞춤의료에 대한 관심이 높아지고 첨단 치료제의 개발로 인해 맞춤형 단백질 생산 시스템에 대한 수요가 증가하고 있습니다. 박테리오바이러스 발현 시스템은 유연성과 다양한 단백질을 생산할 수 있는 능력으로 이러한 수요를 충족시킬 수 있습니다.

본 조사의 주요 특징

• 세계의 바큐로바이러스 발현 시스템 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 2025-2032년까지의 예측 기간(시장 규모 및 CAGR 등)에 대해 조사 분석하여 전해드립니다.
• 이 보고서는 다양한 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 세계 박테리오바이러스 발현 시스템 시장의 주요 기업 프로파일, 기업 개요, 제품 포트폴리오, 주요 특징, 실적, 전략 등을 조사하여 전해드립니다.
• 주요 기업으로는 Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, Virovek 등이 있습니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 바큐로바이러스 발현 시스템 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자는 세계 박테리오바이러스 발현 시스템 시장 분석에 사용되는 전략 매트릭스를 통해 이익을 얻을 수 있으며, 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매/승인
• PEST 분석
• PORTER 분석
• 인수합병(M&A) 시나리오

제4장 세계의 바큐로바이러스 발현 시스템 시장　- 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 바큐로바이러스 발현 시스템 시장 : 제품 유형별, 2020년-2032년

• 바큐로바이러스
• 발현 벡터
• 시약
• 기타

제6장 세계의 바큐로바이러스 발현 시스템 시장 : 용도별, 2020년-2032년

• 치료제
• 백신
• 단백질 정제
• 기타

제7장 세계의 바큐로바이러스 발현 시스템 시장 : 최종사용자별, 2020년-2032년

• 바이오의약품 기업
• 연구기관
• 기타

제8장 세계의 바큐로바이러스 발현 시스템 시장 : 지역별, 2020년-2032년

• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동 및 아프리카
  • GCC
  • 중동 및 북아프리카
  • 중앙아프리카
  • 남아프리카
  • 기타 중동 및 아프리카

제9장 경쟁 구도

• Thermo Fisher Scientific
• Merck KGaA
• Takara Bio
• Agilent Technologies
• Oxford Expression Technologies
• Promega Corporation
• Qiagen N.V.
• Bio-Rad Laboratories
• New England Biolabs
• Genscript Biotech Corporation
• Syngene International Limited
• Sartorius AG
• Aragen Bioscience
• Vivopure
• Creative Biogene
• Absolute Antibody
• Rockland Immunochemicals
• Protein Technologies, Inc.(PTI)
• Proteogenix
• Virovek

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

A baculovirus expression system is a highly versatile and widely utilized tool in biotechnology for the production of recombinant proteins. Baculovirus is an insect virus that infects insect cells, and they have been engineered to express foreign genes of interest. This system offers several advantages over other expression systems including high protein yields, post-translational modifications, and scalability.

The baculovirus expression system has found applications in various fields such as biopharmaceutical production, protein research, vaccine development, and gene therapy. The system has been extensively studied and optimized over the years, leading to improved efficiency and versatility.

Market Dynamics:

The global baculovirus expression system market is expected to witness significant growth in the coming years. Several factors are driving this growth, including the increasing demand for recombinant proteins for therapeutic and research purposes. The system's ability to produce high levels of complex and functional proteins has made it a preferred choice in the biopharmaceutical industry.

Another driver of the market is the rising investments in research and development activities for the development of novel therapies and vaccines. The baculovirus expression system provides a reliable and cost-effective platform for the production of these biologics.

However, the market also faces certain restraints. One of the major challenges is the complex and time-consuming process of protein production using the baculovirus expression system. The optimization and scaling-up of the system requires technical expertise and can be labor-intensive.

Nevertheless, the market presents numerous opportunities for growth. The increasing focus on personalized medicine and the development of advanced therapeutics creates a demand for customized protein production systems. The baculovirus expression system, with its flexibility and ability to produce a wide range of proteins, is well-positioned to meet this demand.

Key Features of the Study:

• This report provides an in-depth analysis of the global baculovirus expression system market including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, with 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• Key players in the global baculovirus expression system market are profiled including company highlights, product portfolios, key highlights, financial performance, and strategies
• The key companies covered in this study include Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, and Virovek
• Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics
• The global baculovirus expression system market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would benefit from the strategy matrices used in analyzing the global baculovirus expression system market, making decision-making easier

Global Baculovirus Expression System Market Segmentation:

• By Product Type
  • Baculovirus
  • Expression Vector
  • Reagents
  • Others
• By Application
  • Therapeutics
  • Vaccines
  • Protein Purification
  • Others
• By End User
  • Biopharmaceutical Companies
  • Research Institutes
  • Others
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Thermo Fisher Scientific
  • Merck KGaA
  • Takara Bio
  • Agilent Technologies
  • Oxford Expression Technologies
  • Promega Corporation
  • Qiagen N.V.
  • Bio-Rad Laboratories
  • New England Biolabs
  • Genscript Biotech Corporation
  • Syngene International Limited
  • Sartorius AG
  • Aragen Bioscience
  • Vivopure
  • Creative Biogene
  • Absolute Antibody
  • Rockland Immunochemicals
  • Protein Technologies, Inc. (PTI)
  • Proteogenix
  • Virovek

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Baculovirus Expression System Market, By Product Type
  • Global Baculovirus Expression System Market, By Application
  • Global Baculovirus Expression System Market , By End User
  • Global Baculovirus Expression System Market , By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• The increasing demand for recombinant proteins for therapeutic and research purposes
  • Restraints
• The complex and time-consuming process of protein production
  • Opportunities
• The increasing focus on personalized medicine and the development of advanced therapeutics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Baculovirus Expression System Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Baculovirus Expression System Market, By Product Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Baculovirus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Expression Vector
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Baculovirus Expression System Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Protein Purification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Baculovirus Expression System Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Baculovirus Expression System Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032,(US$ Mn)
    • U.S
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
    • U.K
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2020 - 2032, (US$ Mn)
    • GCC
    • IsraelNorth Africa
    • Central Africa
    • South Africa
    • Rest of Middle East & Africa

9. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Takara Bio
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Oxford Expression Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Promega Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Qiagen N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• New England Biolabs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Genscript Biotech Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Syngene International Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sartorius AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Aragen Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vivopure
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Creative Biogene
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Absolute Antibody
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Rockland Immunochemicals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Protein Technologies, Inc. (PTI)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Proteogenix
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Virovek
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us